Enovis Corporation (ENOV) ニュース

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Form 8-K - Current report

Form 424B7 - Prospectus [Rule 424(b)(7)]

Enovis™ Announces Leadership Change to International Surgical Business

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator...

Form 8-K - Current report

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600 PR Newswire NEW YORK, Jan. 7, 2025 NEW YORK, Jan. 7, 2025...

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Enovis Announces Third Quarter 2024 Results

Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted...

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical...

Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting

Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical...